Publicaciones en colaboración con investigadores/as de West Virginia University (14)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain

    Pain Management, Vol. 13, Núm. 2, pp. 115-127

  2. Mechanical Thrombectomy Global Access for Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study

    Circulation, Vol. 147, Núm. 16, pp. 1208-1220

2022

  1. Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

    European Journal of Haematology, Vol. 108, Núm. 1, pp. 73-83

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

    Journal of Clinical Oncology, Vol. 39, Núm. 25, pp. 2779-2790

2020

  1. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

    Leukemia and Lymphoma, Vol. 61, Núm. 8, pp. 1850-1859

  2. Mediterranean Diet and Telomere Length: A Systematic Review and Meta-Analysis

    Advances in nutrition (Bethesda, Md.), Vol. 11, Núm. 6, pp. 1544-1554

2018

  1. A phase I/II dose-escalation study investigating all-oral ixazomib-melphalanprednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma

    Haematologica, Vol. 103, Núm. 9, pp. 1518-1526

2017

  1. Reexamining CEO duality: The surprisingly problematic issues of conceptualization and measurement

    Corporate Governance: An International Review, Vol. 25, Núm. 6, pp. 411-427

2015

  1. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead

    Carcinogenesis, Vol. 36, pp. S254-S296

2012

  1. The distributional effects of NAFTA in Mexico: Evidence from a panel of municipalities

    Regional Science and Urban Economics, Vol. 42, Núm. 1-2, pp. 286-302

2011

  1. Identifying polyglutamine protein species in situ that best predict neurodegeneration

    Nature Chemical Biology, Vol. 7, Núm. 12, pp. 925-934